Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.39 |
| ▸ | TACR1 | P25103 | 6/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26413410 | 0.91 | TACR1 (0.45) | OPRM1TACR1HDAC1SLC6A4KCNH2 | |
| SCHEMBL26478677 | 0.91 | OPRM1 (0.43) | OPRM1TACR1HDAC1SLC6A4KCNH2 | |
| SCHEMBL24944306 | 0.87 | TACR1 (0.42) | OPRM1TACR1HDAC1SLC6A4KCNH2 | |
| SCHEMBL26478659 | 0.87 | OPRM1 (0.40) | OPRM1TACR1HDAC1SLC6A4KCNH2 | |
| SCHEMBL24944622 | 0.84 | KCNA3 (0.42) | OPRM1TACR1ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL26478634 | 0.84 | GAA (0.45) | OPRM1ALDH1A1GAASMN1; SMN2NPSR1 | |
| SCHEMBL26478661 | 0.83 | OPRM1 (0.38) | OPRM1TACR1HDAC1SLC6A4KCNH2 | |
| SCHEMBL24944620 | 0.82 | DRD2 (0.43) | OPRM1TACR1HDAC1SLC6A4PTGDR2 | |
| SCHEMBL26478635 | 0.82 | HDAC1 (0.41) | OPRM1HDAC1KCNH2ALDH1A1GAA | |
| SCHEMBL26478648 | 0.82 | ALOX5 (0.43) | OPRM1ALDH1A1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | HNRNPU, NSUN2, HNRNPR | OPRM1 775/4885TACR1 2183/4885HDAC1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.